Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7%

December 11, 2025

•

1 min read

•

Investor's Business Daily

Eli Lily stock edged higher as the drug giant said its experimental obesity treatment delivered 23.7% weight loss.

Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we ... [1013 chars]

Read Original Article

Source: Investor's Business Daily

Visit Source

Share this article

Twitter Facebook

Back to business news